Metabonomics in ulcerative colitis: Diagnostics, biomarker identification, and insight into the pathophysiology

Journal of Proteome Research

Volumn 9, Issue 2, 2010, Pages 954-962

  Bjerrum, Jacob T ^a   Nielsen, Ole H ^a   Hao, Fuhua ^b   Tang, Huiru ^b   Nicholson, Jeremy K ^c   Wang, Yulan ^b   Olsen, Jørgen ^d  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Wuhan National Laboratory for Optoelectronics   (China)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Biomarker identification; Diagnostics; Metabonomics; NMR spectroscopy; Ulcerative colitis

Indexed keywords

ACETIC ACID; ALANINE; ALCOHOL; ANTIOXIDANT; ASCORBIC ACID; ASPARAGINE; ASPARTIC ACID; BETAINE; BIOLOGICAL MARKER; CHOLINE; CREATINE; CREATININE; GLUTAMIC ACID; GLUTAMINE; GLUTATHIONE; GLYCEROPHOSPHORYLCHOLINE; GLYCOPROTEIN; INOSITOL; ISOLEUCINE; LACTIC ACID; LEUCINE; LIPID; LYSINE; PHOSPHATIDYLCHOLINE; PHOSPHOETHANOLAMINE; PROPYLENE GLYCOL; TAURINE; VALINE;

ADULT; AGED; ARTICLE; BIOMICS; CELL ISOLATION; COLON BIOPSY; COLONOCYTE; COLONOSCOPE; COMPUTER PROGRAM; CONTROLLED STUDY; DATA ANALYSIS; DESCENDING COLON; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INTESTINE CELL; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; METABOLISM; METABOLITE; METABONOMICS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; ULCERATIVE COLITIS; URINALYSIS;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; BIOPSY; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; FEMALE; HUMANS; INTESTINAL MUCOSA; MAGNETIC RESONANCE SPECTROSCOPY; MALE; METABOLOMICS; MIDDLE AGED; MULTIVARIATE ANALYSIS; YOUNG ADULT;

EID: 76149113262     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr9008223     Document Type: Article

References (45)

1. Strober, W.; Fuss, I.; Mannon, P. The fundamental basis of inflammatory bowel disease. J. Clin. Invest. 2007, 117, 514-521.
2. Colombel, J. F.; Watson, A. J.; Neurath, M. F. The 10 remaining mysteries of inflammatory bowel disease. Gut. 2008, 57, 429-433.
3. Berndt, U.; Bartsch, S.; Philipsen, L.; Danese, S.; Wiedenmann, B.; Dignass, A. U.; Hammerle, M.; Sturm, A. Proteomic analysis of the inflamed intestinal mucosa reveals distinctive immune response profiles in Crohn's disease and ulcerative colitis. J. Immunol. 2007, 179, 295-304.
4. Wu, F.; Dassopoulos, T.; Cope, L.; Maitra, A.; Brant, S. R.; Harris, M. L.; Bayless, T. M.; Parmigiani, G.; Chakravarti, S. Genome-wide gene expression differences in Crohn's disease and ulcerative colitis from endoscopic pinch biopsies: insights into distinctive pathogenesis. Inflamm. Bowel Dis. 2007, 13, 807-821.
5. Olsen, J.; Gerds, T. A.; Seidelin, J. B.; Csillag, C.; Bjerrum, J. T.; Troelsen, J. T.; Nielsen, O. H. Diagnosis of ulcerative colitis before onset of inflammation by multivariate modeling of genome-wide gene expression data. Inflamm. Bowel Dis. 2009, 15, 1032-1038.
6. Nicholson, J. K.; Lindon, J. C.; Holmes, E. 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 1999, 29, 1181-1189.
7. Wang, Y.; Holmes, E.; Comelli, E. M.; Fotopoulos, G.; Dorta, G.; Tang, H.; Rantalainen, M. J.; Lindon, J. C.; Corthesy-Theulaz, I. E.; Fay, L. B.; Kochhar, S.; Nicholson, J. K. Topographical variation in metabolic signatures of human gastrointestinal biopsies revealed by high-resolution magic-angle spinning 1H NMR spectroscopy. J. Proteome Res. 2007, 6, 3944-3951.
8. Bjerrum, J. T.; Nielsen, O. H.; Wang, Y. L.; Olsen, J. Technology insight: metabonomics in gastroenterology-basic principles and potential clinical applications. Nat. Clin. Pract. Gastroenterol. Hepatol. 2008, 5, 332-343.
9. Balasubramanian, K.; Kumar, S.; Singh, R. R.; Sharma, U.; Ahuja, V.; Makharia, G. K.; Jagannathan, N. R. Metabolism of the colonic mucosa in patients with inflammatory bowel diseases: an in vitro proton magnetic resonance spectroscopy study. Magn. Reson. Imaging 2009, 27, 79-86.
10. Bezabeh, T.; Somorjai, R. L.; Smith, I. C.; Nikulin, A. E.; Dolenko, B.; Bernstein, C. N. The use of 1H magnetic resonance spectroscopy in inflammatory bowel diseases: distinguishing ulcerative colitis from Crohn's disease. Am. J. Gastroenterol. 2001, 96, 442-448.
11. Marchesi, J. R.; Holmes, E.; Khan, F.; Kochhar, S.; Scanlan, P.; Shanahan, F.; Wilson, I. D.; Wang, Y. Rapid and noninvasive metabonomic characterization of inflammatory bowel disease. J. Proteome Res. 2007, 6, 546-551.
12. Spiller, R. Clinical update: irritable bowel syndrome. Lancet 2007, 369, 1586-1588.
13. Nikolaus, S.; Schreiber, S. Diagnostics of inflammatory bowel disease. Gastroenterology. 2007, 133, 1670-1689.
14. Schroeder, K. W.; Tremaine, W. J.; Ilstrup, D. M. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N. Engl. J. Med. 1987, 317, 1625-1629.
15. Bentley, E.; Jenkins, D.; Campbell, F.; Warren, B. How could pathologists improve the initial diagnosis of colitis? Evidence from an international workshop. J. Clin. Pathol. 2002, 55, 955-960.
16. Seidelin, J. B.; Horn, T.; Nielsen, O. H. Simple and efficient method for isolation and cultivation of endoscopically obtained human colonocytes. Am. J. Physiol. Gastrointest. Liver Physiol. 2003, 285, G1122-G1128.
17. Seidelin, J. B.; Nielsen, O. H. Attenuated apoptosis response to Fasligand in active ulcerative colitis. Inflamm. Bowel Dis. 2008, 14, 1623-1629.
18. Waters, N. J.; Garrod, S.; Farrant, R. D.; Haselden, J. N.; Connor, S. C.; Connelly, J.; Lindon, J. C.; Holmes, E.; Nicholson, J. K. Highresolution magic angle spinning (1)H NMR spectroscopy of intact liver and kidney: optimization of sample preparation procedures and biochemical stability of tissue during spectral acquisition. Anal. Biochem. 2000, 282, 16-23.
19. 13C NMR spectroscopy of human blood plasma. Anal. Chem. 1995, 67, 793-811.
20. Meiboom, S.; Gill, D. Modified Spin-Echo method for measuring nuclear relaxation times. Rev. Sci. Instrum. 1958, 29, 688-691.
21. Hurd, R. E. Gradient-enhanced spectroscopy. J. Magn. Reson. 1990, 87, 422-428.
22. Bax, A.; Davis, D. G. MELV-17-based two-dimensional homonuclear magnetization transfer spectroscopy. J. Magn. Reson. 1985, 65, 355-360.
23. Bylesjö, M.; Rantalainen, M.; Cloarec, O.; Nicholson, J. K.; Holmes, E.; Trygg, J. OPLS discriminant analysis: combining the strengths of PLS-DA and SIMCA classification. J. Chemom. 2006, 20, 341-351.
24. Wold, S.; Ruhe, A.; Wold, H.; Dunn, W. J. The collinearity problem in linear-regression - the partial least-squares (Pls) approach to generalized inverses. SIAM J. Sci. Stat. Comput. 1984, 5, 735-743.
25. Wold, S.; Antti, H.; Lindgren, F.; Ohman, J. Orthogonal signal correction of near-infrared spectra. Chemom. Intell. Lab. 1998, 44, 175-185.
26. Cloarec, O.; Dumas, M. E.; Trygg, J.; Craig, A.; Barton, R. H.; Lindon, J. C.; Nicholson, J. K.; Holmes, E. Evaluation of the orthogonal projection on latent structure model limitations caused by chemical shift variability and improved visualization of biomarker changes in H-1 NMR spectroscopic metabonomic studies. Anal. Chem. 2005, 77, 517-526.
27. Murdoch, T. B.; Fu, H.; MacFarlane, S.; Sydora, B. C.; Fedorak, R. N.; Slupsky, C. M. Urinary metabolic profiles of inflammatory bowel disease in interleukin-10 gene-deficient mice. Anal. Chem. 2008, 80, 5524-5531.
28. Williams, H. R.; Cox, I. J.; Walker, D. G.; North, B. V.; Patel, V. M.; Marshall, S. E.; Jewell, D. P.; Ghosh, S.; Thomas, H. J.; Teare, J. P.; Jakobovits, S.; Zeki, S.; Welsh, K. I.; Taylor-Robinson, S. D.; Orchard, T. R. Characterization of inflammatory bowel disease with urinary metabolic profiling. Am. J. Gastroenterol. 2009, 104, 1435-1444.
29. Kretzmann, N. A.; Fillmann, H.; Mauriz, J. L.; Marroni, C. A.; Marroni, N.; Gonzalez-Gallego, J.; Tunon, M. J. Effects of glutamine on proinflammatory gene expression and activation of nuclear factor kappa B and signal transducers and activators of transcription in TNBS-induced colitis. Inflamm. Bowel Dis. 2008, 14, 1504-1513.
30. 31P heteronuclear statistical total correlation spectroscopy of intact human gut biopsies. Anal. Chem. 2008, 80, 1058-1066.
31. Jones, D. P. Redox potential of GSH/GSSG couple: assay and biological significance. Methods Enzymol. 2002, 348, 93-112.
32. Giris, M.; Depboylu, B.; Dogru-Abbasoglu, S.; Erbil, Y.; Olgac, V.; Alis, H.; ykac-Toker, G.; Uysal, M. Effect of taurine on oxidative stress and apoptosis-related protein expression in trinitrobenzene sulphonic acid-induced colitis. Clin. Exp. Immunol. 2008, 152, 102-110.
33. Ziegler, T. R.; Bazargan, N.; Leader, L. M.; Martindale, R. G. Glutamine and the gastrointestinal tract. Curr. Opin. Clin. Nutr. Metab. Care. 2000, 3, 355-362.
34. Ameho, C. K.; Adjei, A. A.; Harrison, E. K.; Takeshita, K.; Morioka, T.; Arakaki, Y.; Ito, E.; Suzuki, I.; Kulkarni, A. D.; Kawajiri, A.; Yamamoto, S. Prophylactic effect of dietary glutamine supplementation on interleukin 8 and tumour necrosis factor alpha production in trinitrobenzene sulphonic acid induced colitis. Gut 1997, 41, 487-493.
35. Ockenga, J.; Borchert, K.; Stuber, E.; Lochs, H.; Manns, M. P.; Bischoff, S. C. Glutamine-enriched total parenteral nutrition in patients with inflammatory bowel disease. Eur. J. Clin. Nutr. 2005, 59, 1302-1309.
36. Finnie, I. A.; Taylor, B. A.; Rhodes, J. M. Ileal and colonic epithelial metabolism in quiescent ulcerative colitis: increased glutamine metabolism in distal colon but no defect in butyrate metabolism. Gut. 1993, 34, 1552-1558.
37. Chapman, M. A.; Grahn, M. F.; Boyle, M. A.; Hutton, M.; Rogers, J.; Williams, N. S. Butyrate oxidation is impaired in the colonic mucosa of sufferers of quiescent ulcerative colitis. Gut 1994, 35, 73-76.
38. Duffy, M. M.; Regan, M. C.; Ravichandran, P.; O'Keane, C.; Harrington, M. G.; Fitzpatrick, J. M.; O'Connell, P. R. Mucosal metabolism in ulcerative colitis and Crohn's disease. Dis. Colon Rectum. 1998, 41, 1399-1405.
39. Ruan, E. A.; Rao, S.; Burdick, J. S.; Stryker, J. S.; Telford, G. L.; Otterson, M. F.; Opara, E. C.; Koch, T. R. Glutathione levels in chronic inflammatory disorders of the human colon. Nutr. Res. (N. Y., NY, U.S.) 1997, 17, 463-473.
40. Holmes, E. W.; Yong, S. L.; Eiznhamer, D.; Keshavarzian, A. Glutathione content of colonic mucosa: evidence for oxidative damage in active ulcerative colitis. Dig. Dis. Sci. 1998, 43, 1088-1095.
41. Innis, S. M.; Davidson, A. G. Cystic fibrosis and nutrition: linking phospholipids and essential fatty acids with thiol metabolism. Annu. Rev. Nutr. 2008, 28, 55-72.
42. Holmes-McNary, M. Q.; Baldwin, A. S., Jr.; Zeisel, S. H. Opposing regulation of choline deficiency-induced apoptosis by p53 and nuclear factor kappaB. J. Biol. Chem. 2001, 276, 41197-41204.
43. Liao, J.; Seril, D. N.; Yang, A. L.; Lu, G. G.; Yang, G. Y. Inhibition of chronic ulcerative colitis associated adenocarcinoma development in mice by inositol compounds. Carcinogenesis 2007, 28, 446-454.
44. Moreno, A.; Arus, C. Quantitative and qualitative characterization of 1H NMR spectra of colon tumors, normal mucosa and their perchloric acid extracts: decreased levels of myo-inositol in tumours can be detected in intact biopsies. NMR Biomed. 1996, 9, 33-45.
45. Gupta, R. B.; Harpaz, N.; Itzkowitz, S.; Hossain, S.; Matula, S.; Kornbluth, A.; Bodian, C.; Ullman, T. Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study. Gastroenterology 2007, 133, 1099-1105.